| Product Code: ETC5306163 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Similar to the pneumonia vaccine market, Andorra`s market for polio vaccines is likely integrated into regional or global vaccination efforts. While endemic polio has been eradicated in most parts of the world, vaccination remains crucial for preventing outbreaks and maintaining herd immunity, even in small countries like Andorra.
The Andorra polio vaccine market is witnessing significant growth driven by various factors. Firstly, concerted efforts by global health organizations and governments to eradicate polio are bolstering vaccine production and distribution. The introduction of innovative vaccination strategies, such as polio vaccination campaigns and routine immunization programs, is expanding vaccine coverage across the population. Additionally, increasing awareness about the importance of polio vaccination and the dire consequences of polio infection is driving demand for vaccines. Moreover, collaborations between pharmaceutical companies and international organizations to ensure vaccine accessibility and affordability are further fueling market growth. Furthermore, advancements in vaccine technology, including the development of new vaccine formulations and delivery methods, are contributing to market expansion. Overall, the Andorra polio vaccine market is characterized by promising growth prospects as efforts to eliminate polio intensify globally.
While polio has been largely eradicated, challenges persist in ensuring sustained vaccination coverage in Andorra. Maintaining high vaccination rates to prevent polio resurgence requires overcoming logistical hurdles, addressing vaccine shortages, and combating misinformation about vaccines. Moreover, reaching remote or underserved populations poses additional challenges in achieving universal polio immunization.
The Andorran government places a high priority on public health, including the procurement and distribution of essential vaccines such as those for polio. Policies governing the polio vaccine market focus on ensuring accessibility, affordability, and safety for all residents. Through strategic partnerships with international organizations and pharmaceutical companies, the government procures vaccines in bulk quantities to negotiate favorable pricing terms. Furthermore, extensive vaccination campaigns are conducted nationwide, targeting both children and adults to maintain herd immunity and prevent the resurgence of polio outbreaks. Strict quality control measures are also enforced to guarantee the efficacy and safety of vaccines distributed within the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Polio Vaccine Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Polio Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Polio Vaccine Market - Industry Life Cycle |
3.4 Andorra Polio Vaccine Market - Porter's Five Forces |
3.5 Andorra Polio Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Andorra Polio Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Andorra Polio Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of polio vaccination in Andorra |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Rising healthcare expenditure in Andorra |
4.3 Market Restraints |
4.3.1 Limited availability of polio vaccines in Andorra |
4.3.2 High cost associated with polio vaccines |
4.3.3 Vaccine hesitancy among a certain segment of the population in Andorra |
5 Andorra Polio Vaccine Market Trends |
6 Andorra Polio Vaccine Market Segmentations |
6.1 Andorra Polio Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Andorra Polio Vaccine Market Revenues & Volume, By Oral Polio Vaccine (OPV), 2021-2031F |
6.1.3 Andorra Polio Vaccine Market Revenues & Volume, By Inactivated Poliomyelitis Vaccine (IPV), 2021-2031F |
6.2 Andorra Polio Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Andorra Polio Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.2.3 Andorra Polio Vaccine Market Revenues & Volume, By Private, 2021-2031F |
7 Andorra Polio Vaccine Market Import-Export Trade Statistics |
7.1 Andorra Polio Vaccine Market Export to Major Countries |
7.2 Andorra Polio Vaccine Market Imports from Major Countries |
8 Andorra Polio Vaccine Market Key Performance Indicators |
8.1 Percentage increase in polio vaccine coverage rate in Andorra |
8.2 Number of government-supported vaccination campaigns conducted annually |
8.3 Average waiting time for individuals to receive polio vaccination at healthcare facilities in Andorra |
9 Andorra Polio Vaccine Market - Opportunity Assessment |
9.1 Andorra Polio Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Andorra Polio Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Andorra Polio Vaccine Market - Competitive Landscape |
10.1 Andorra Polio Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Andorra Polio Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |